TET2 and hydrops fetalis: In addition, CHIP forecasted the onset of HF, but common CHDMs, such as DNMT3A and TET2, did not forecast LVEF reduction, suggesting that CHIP predicts HFpEF onset in a subset of patients with CHIP [82].